IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Merck KGaA May Divest Generics

1:37 PM MDT | January 10, 2007 | Chemical Week Editorial Staff

Merck KGaA is considering plans to divest its generic drugs business and could raise up to €4 billion ($5.3 billion) from the sale, according to a report in German newspaper Handelsblatt on January 4. Merck KGaA declined to comment on the report. Selling generics would cut Merck KGaA’s debt following the company’s imminent purchase of biotechnology firm Serono for over $13 billion. Private equity firms, rather than pharmaceutical manufacturers, are more likely to be interested in buying Merck KGaA’s generics, analysts say. Merck KGaA is one...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa